Tentarix Biotherapeutics
About:
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Website: https://www.tentarix.com
Top Investors: Samsara BioCapital, Amplitude Venture Capital, Gilead Sciences, Versant Ventures
Description:
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Total Funding Amount:
$93M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)tentarix.com
Founders:
Margaret Karow, Paul Grayson
Number of Employees:
11-50
Last Funding Date:
2023-09-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai